Precision Biosciences (DTIL) Goodwill & Intangibles (2018 - 2026)
Precision Biosciences (DTIL) reported Goodwill & Intangibles of $1.1 million for Q1 2026, up 85.67% year-over-year from $607000.0 in Q1 2025, and down 3.34% on a QoQ basis from $1.2 million in Q4 2025.
Precision Biosciences (DTIL) has 9 years of Goodwill & Intangibles data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Goodwill & Intangibles rose 85.67% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 85.67% YoY) and the FY2025 annual result came in at $1.2 million, up 87.46% from the prior year.
- Goodwill & Intangibles declined to $1.1 million in Q1 2026 per DTIL's latest filing, from $1.2 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $2.0 million in Q1 2022 and bottomed at $375000.0 in Q2 2024.
- The 5-year median for Goodwill & Intangibles is $977000.0 (2023), against an average of $1.0 million.
- The widest annual swing landed in 2024, when Goodwill & Intangibles sank 75.84%; it then surged 153.87% in 2025.
- Tracing DTIL's Goodwill & Intangibles over 5 years: stood at $731000.0 in 2022, then tumbled by 45.28% to $400000.0 in 2023, then soared by 55.5% to $622000.0 in 2024, then jumped by 87.46% to $1.2 million in 2025, then fell by 3.34% to $1.1 million in 2026.
- Per Business Quant, the three latest DTIL Goodwill & Intangibles figures stand at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $985000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 985,000.00 |
| Jun 30, 2025 | 605,000.00 |
| Mar 31, 2025 | 607,000.00 |
| Dec 31, 2024 | 622,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 375,000.00 |
| Mar 31, 2024 | 386,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 977,000.00 |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 731,000.00 |
| Sep 30, 2022 | 1.97 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 2.02 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 2.07 Mn |
| Jun 30, 2021 | 1.34 Mn |
| Mar 31, 2021 | 1.36 Mn |
| Dec 31, 2020 | 1.37 Mn |
| Sep 30, 2020 | 1.39 Mn |
| Jun 30, 2020 | 1.40 Mn |
| Mar 31, 2020 | 1.42 Mn |
| Dec 31, 2019 | 1.43 Mn |
| Sep 30, 2019 | 1.45 Mn |
| Jun 30, 2019 | 1.45 Mn |
| Mar 31, 2019 | 1.46 Mn |
| Dec 31, 2018 | 1.47 Mn |